Gérard Botton

USPTO Granted Patents = 13 (Patent Applications = 1)

CIPO Patents = 2

EPO Patents = 5 (Patent Applications = 6)

Average Co-Inventor Count = 4.4

ph-index = 1

Forward Citations = 3(Granted Patents)

Company Filing History:

Merck Patent Gesellschaft MIT Beschrankter Haftung

patents

1 out of 100

Merck Patent Gesellschaft MIT Beschraenkter Haftung

patents

Years Active: 2010-2016

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9233937 - Method of stimulating insulin secretion and/or modulating INS-1 kinase with substituted pyrazinones and/or substituted tetrahydroquinoxalinones (2016-01-12),

2. 9102632 - Pyrazinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes (2015-08-11),

3. 8835634 - Quinoxalinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes (2014-09-16),

4. 8815859 - Substituted pyrazin-2-ones and substituted 5,6,7,8-tetrahydroquinoxalin-2-ones and methods of use thereof (2014-08-26),

5. 8673955 - Imidazole derivatives as fructose-1,6-bisphosphatase inhibitors and pharmaceutical compositions containing them (2014-03-18),

6. 8642617 - Pyridopyrazinones derivatives insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes (2014-02-04),

7. 8637522 - Pyrazinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes (2014-01-28),

8. 8609689 - Pyridopyrazinones derivatives insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes (2013-12-17),

9. 8415352 - Quinoxalinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes (2013-04-09),

10. 8362057 - Imidazolecarboxamide derivatives as fructose-1,6-bisphosphatase inhibitors, and pharmaceutical compositions comprising same (2013-01-29),

11. 8232272 - Benzimidazoledihydrothiadiazinone derivatives as fructose-1,6-bisphosphatase inhibitors, and pharmaceutical compositions comprising same (2012-07-31),

12. 8178556 - Pyridopyrazinones derivatives insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes (2012-05-15),

13. 7816397 - Phenylcarboxylic acid derivatives and use thereof for the treatment of diabetes (2010-10-19),

Title: The Innovative Contributions of Gérard Botton

Introduction

Gérard Botton is a notable inventor based in Buc, France, recognized for his significant contributions to the field of pharmaceuticals. With a total of seven patents to his name, he has made strides in developing innovative compounds aimed at treating various medical conditions.

Latest Patents

Among his latest patents are the "Substituted pyrazin-2-ones and substituted 5,6,7,8-tetrahydroquinoxalin-2-ones and methods of use thereof," which focuses on arylpyrazinone derivatives that act as insulin secretion stimulators. These compounds are particularly relevant for the prophylaxis and treatment of diabetes and related pathologies. Another notable patent involves "Imidazole derivatives as fructose-1,6-bisphosphatase inhibitors and pharmaceutical compositions containing them," which details imidazole derivatives designed to inhibit specific enzymes, showcasing his innovative approach to pharmaceutical development.

Career Highlights

Gérard Botton has had a distinguished career, working with prominent companies such as Merck Patent GmbH and Merck Patent Gesellschaft mit beschränkter Haftung. His experience in these organizations has allowed him to refine his expertise in patent development and pharmaceutical research.

Collaborations

Throughout his career, Gérard has collaborated with esteemed colleagues, including Micheline R. Kergoat and Christine G.

This text is generated by artificial intelligence and may not be accurate.